Pyridinylmorpholine derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S106000, C544S111000, C544S124000, C514S231200, C514S231500, C514S235500

Reexamination Certificate

active

07488728

ABSTRACT:
The invention relates to compounds of formula (I):wherein R, R1, R2and X are defined herein, their preparation, and their use as pharmaceuticals.

REFERENCES:
patent: 7294623 (2007-11-01), Clark et al.
patent: 2 060 622 (1981-05-01), None
patent: 2 167 407 (1986-05-01), None
patent: WO 99/15177 (1999-04-01), None
patent: WO 00/39091 (2000-07-01), None
patent: WO 01/01973 (2001-01-01), None
patent: WO 03/106441 (2003-12-01), None
patent: WO 2004/017977 (2004-03-01), None
patent: WO 2004/018440 (2004-03-01), None
International Search Report.
Thornber C.W., “Isosterism and Molecular Modification in Drug Design”,Chemical Society Reviews, vol. 8, No. 4, 1979, pp. 563-580.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pyridinylmorpholine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyridinylmorpholine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridinylmorpholine derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4092771

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.